Serum angiotensin-converting enzyme level as a marker of fibrosis in patients with chronic hepatitis B | Zendy

Tuğrul Pürnak | Zendy; Yavuz Beyazıt | Zendy; Erkin Öztaş | Zendy; Yusuf Yeşil | Zendy; Cumali Efe | Zendy; Serkan Torun | Zendy; Tuğrul Çelik | Zendy; İlyas Tenlik | Zendy; Mevlüt Kurt | Zendy; Ersan Özaslan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Serum angiotensin-converting enzyme level as a marker of fibrosis in patients with chronic hepatitis B

Author(s) -

Tuğrul Pürnak,

Yavuz Beyazıt,

Erkin Öztaş,

Yusuf Yeşil,

Cumali Efe,

Serkan Torun,

Tuğrul Çelik,

İlyas Tenlik,

Mevlüt Kurt,

Ersan Özaslan

Publication year - 2012

Publication title -

journal of the renin-angiotensin-aldosterone system

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.457

H-Index - 46

eISSN - 1752-8976

pISSN - 1470-3203

DOI - 10.1177/1470320311434241

Subject(s) - medicine , gastroenterology , fibrosis , context (archaeology) , receiver operating characteristic , hepatitis b virus , liver biopsy , hepatitis b , biopsy , immunology , virus , paleontology , biology

and aims: Hepatitis B virus (HBV) infection is a public health problem and affects nearly 350 million people worldwide. The present study was conducted in order to investigate the role of circulating angiotensin-converting enzyme (ACE) in the context of renin-angiotensin-aldosterone in newly diagnosed chronic hepatitis B infection. Moreover the association between liver fibrosis and serum ACE levels was also investigated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research